Norepinephrine-targeted Therapy for Action Control in Parkinson Disease

NCT03115827 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Droxidopa
DRUG: Carbidopa

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]